Faculty Publications

Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan (Zevalin) and gemicitabine in patients with non-hodgkin's lymphoma

Borghaei H, Smith M, Millenson M, Thibodeau L, Kamiensky N, Schilder RJ

Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan (Zevalin) and gemicitabine in patients with non-hodgkin's lymphoma

Blood. 2007 Nov;110(11):192B-193B.

Abstract

Last updated on Saturday, November 21, 2009